Product NDC: | 62856-241 |
Proprietary Name: | AcipHex Sprinkle |
Non Proprietary Name: | rabeprazole sodium |
Active Ingredient(s): | 10 mg/1 & nbsp; rabeprazole sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | GRANULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62856-241 |
Labeler Name: | Eisai Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA204736 |
Marketing Category: | NDA |
Start Marketing Date: | 20130326 |
Package NDC: | 62856-241-30 |
Package Description: | 30 CAPSULE in 1 BOTTLE (62856-241-30) > 1 GRANULE, DELAYED RELEASE in 1 CAPSULE |
NDC Code | 62856-241-30 |
Proprietary Name | AcipHex Sprinkle |
Package Description | 30 CAPSULE in 1 BOTTLE (62856-241-30) > 1 GRANULE, DELAYED RELEASE in 1 CAPSULE |
Product NDC | 62856-241 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rabeprazole sodium |
Dosage Form Name | GRANULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130326 |
Marketing Category Name | NDA |
Labeler Name | Eisai Inc. |
Substance Name | RABEPRAZOLE SODIUM |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |